BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3093060)

  • 1. Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis.
    Dennis JW
    Cancer Res; 1986 Oct; 46(10):5131-6. PubMed ID: 3093060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine.
    Dennis JW; Koch K; Yousefi S; VanderElst I
    Cancer Res; 1990 Mar; 50(6):1867-72. PubMed ID: 2106389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial reversion of the metastatic phenotype in a wheat germ agglutinin-resistant mutant of the murine tumor cell line MDAY-D2 selected with Bandeiraea simplicifolia seed lectin.
    Dennis JW
    J Natl Cancer Inst; 1985 May; 74(5):1111-20. PubMed ID: 3858579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of asparagine-linked oligosaccharides on murine tumor cells by natural killer cells.
    Dennis JW; Laferté S
    Cancer Res; 1985 Dec; 45(12 Pt 1):6034-40. PubMed ID: 4063962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors.
    Humphries MJ; Matsumoto K; White SL; Olden K
    Cancer Res; 1986 Oct; 46(10):5215-22. PubMed ID: 3093061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of swainsonine in patients with advanced malignancies.
    Goss PE; Baptiste J; Fernandes B; Baker M; Dennis JW
    Cancer Res; 1994 Mar; 54(6):1450-7. PubMed ID: 8137247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different metastatic phenotypes in two genetic classes of wheat germ agglutinin-resistant tumor cell mutants.
    Dennis JW
    Cancer Res; 1986 Sep; 46(9):4594-600. PubMed ID: 3755374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth of subcutaneous xenografts and metastasis of human breast carcinoma by swainsonine: modulation of tumor cell HLA class I antigens and host immune effector mechanisms.
    Mohla S; White S; Grzegorzewski K; Nielsen D; Dunston G; Dickson L; Cha JK; Asseffa A; Olden K
    Anticancer Res; 1990; 10(6):1515-22. PubMed ID: 2126682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-linked oligosaccharide processing and autocrine stimulation of tumor cell proliferation.
    VanderElst I; Dennis JW
    Exp Cell Res; 1991 Feb; 192(2):612-21. PubMed ID: 1899075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of asparagine-linked oligosaccharides on tumor cell recognition in the mixed lymphocyte reaction.
    Powell LD; Bause E; Legler G; Molyneux RJ; Hart GW
    J Immunol; 1985 Jul; 135(1):714-24. PubMed ID: 3158709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of N-linked oligosaccharide processing in tumor cells is associated with enhanced tissue inhibitor of metalloproteinases (TIMP) gene expression.
    Korczak B; Dennis JW
    Int J Cancer; 1993 Feb; 53(4):634-9. PubMed ID: 8436437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different class I antigen oligosaccharides on a murine tumor and a lectin-resistant variant are not responsible for the differential recognition of the tumors by CTL.
    Degen E; Laferté S; Elliott BE; Williams DB
    Int J Cancer; 1989 May; 43(5):828-36. PubMed ID: 2497074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of tumor invasion-inhibiting factor 2 and its conjugate on disseminating tumor cells.
    Isoai A; Goto-Tsukamoto H; Yamori T; Oh-hara T; Tsuruo T; Silletti S; Raz A; Watanabe H; Akedo H; Kumagai H
    Cancer Res; 1994 Mar; 54(5):1264-70. PubMed ID: 8118815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenicity of tumor cell populations: origin of a putative H-2 isoantigenic loss variant tumor.
    Kerbel RS; Florian M; Man MS; Dennis J; McKenzie IF
    J Natl Cancer Inst; 1980 May; 64(5):1221-30. PubMed ID: 6929020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex: a new biological activity.
    Hirabayashi K; Yano J; Inoue T; Yamaguchi T; Tanigawara K; Smyth GE; Ishiyama K; Ohgi T; Kimura K; Irimura T
    Cancer Res; 1999 Sep; 59(17):4325-33. PubMed ID: 10485480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosphingolipids of lectin-resistant mutants of the highly metastatic mouse tumor cell line, MDAY-D2.
    Laferté S; Fukuda MN; Fukuda M; Dell A; Dennis JW
    Cancer Res; 1987 Jan; 47(1):150-9. PubMed ID: 3791202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of processing of asparagine-linked carbohydrate chains on IgG2a by using swainsonine has no influence upon antibody effector functions in vitro.
    Nose M; Heyman B
    J Immunol; 1990 Aug; 145(3):910-4. PubMed ID: 2115547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells.
    Humphries MJ; Matsumoto K; White SL; Olden K
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1752-6. PubMed ID: 3081900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator.
    Humphries MJ; Matsumoto K; White SL; Molyneux RJ; Olden K
    Cancer Res; 1988 Mar; 48(6):1410-5. PubMed ID: 3125963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.